Pharmaceutical Manufacturer
Risk profile for a pharmaceutical manufacturer (production of active pharmaceutical ingredients, formulation or packaging of medicinal products): the risk attributes typically assessed in underwriting and the resulting commercial insurance programme architecture.
Risk picture
Pharmaceutical manufacturers (production of active pharmaceutical ingredients, formulation, sterile or non-sterile filling, and packaging of medicinal products) carry a liability-dominated risk profile: a manufacturing defect, cross-contamination or labelling error can affect life-sustaining or safety-critical products used by large patient populations, with bodily injury severity, class-action potential and regulatory recall exposure far exceeding what the plant’s own revenue base would suggest. Typical loss drivers are batch contamination or potency deviations discovered only after distribution, product liability claims in jurisdictions with materially higher litigation exposure such as the United States, and recall costs that scale with distribution reach rather than with the size of the affected production run. Property and business interruption exposure, while material given the value of cleanroom and sterile manufacturing infrastructure, is typically secondary to the liability and recall dimension in overall programme design.
Risk attributes to capture
The table below is generated from this profile’s linked risk attributes and grouped by category; see the individual attribute pages for underwriting logic, evidence requirements and mitigation measures.
Coverage architecture
Employee accident cover is compulsory in Switzerland (UVG) wherever staff are employed. The mandatory layer of the commercial programme combines dedicated pharmaceutical/products liability cover with general product liability, since standard general liability wording is typically insufficient for the severity and litigation profile of pharmaceutical claims, particularly where sales reach the United States or Canada. Property all risks and general liability form the core of the programme, covering manufacturing infrastructure and third-party claims arising from site operations; business interruption cover is commonly added given the high value concentration in specialised production and quality-control equipment.
Prevention
Loss prevention priorities are rigorous batch and lot traceability enabling narrowly targeted recalls rather than blanket ones, maintaining current certification against all applicable regulatory and quality standards for every product line and destination market, a formal management-of-change process ensuring that equipment, process or supplier changes are risk-reviewed before implementation to prevent an undetected drift out of validated specification, and close monitoring of revenue and distribution exposure in higher-litigation markets to keep liability programme structure aligned with the actual risk as international sales evolve.
- Kind
- Business
- Classification
- NOGA 21 – Manufacture of basic pharmaceutical products and pharmaceutical preparations, NACE C21
Risk attributes to capture
Liability/Products
- Product Risk Classification — Product risk classification groups an insured's products by the severity of harm they could plausibly cause if defective, ranging from low-hazard goods to safety-critical or life-sustaining products, and drives the underwriting treatment of product liability exposure.
- Recall Potential and History — Recall potential and history records an insured's prior product recalls or field corrective actions together with an assessment of how likely and how costly a future recall would be, given product design, market reach and traceability.
- Product Certification and Standards Compliance — Product certification and standards compliance records which safety, performance or regulatory standards an insured's products are certified against (e.g. CE marking, UL listing, industry-specific norms), since gaps in certification are a leading cause of product liability and recall exposure.
- US/Canada Revenue Share — US/Canada revenue share records the percentage of an insured's turnover generated in or attributable to the United States and Canada, which underwriters treat separately from other export markets due to the materially higher liability litigation exposure in these jurisdictions.
Operations
- Quality Management Certification — Quality management certification records whether an insured's quality system is certified to a recognised standard such as ISO 9001, which underwriters use as an indicator of consistent process control and therefore of product liability and recall risk.
- Management of Change Process — The management of change process attribute records whether an insured operates a formal procedure to review new or modified equipment, processes and organisational arrangements for fire, explosion and liability risk before implementation.
Coverage architecture
Standards and codes
- ISO 31000:2018 – Risk management, Guidelines